Molecular chaperones as key players in tumor suppressor stability

A new review was published in Oncotarget’s Volume 15 on October 1, 2024, entitled, “Molecular chaperones: Guardians of tumor suppressor stability and function.”

MHRA puts technology in the spotlight in 2024/25 business plan – Pharmaceutical Technology

Credit: Ralf Liebhold / Shutterstock. The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has unveiled a new business plan to build on the launch

October 8, 2024

Opinion | Are We Desensitized to Fire Alarms in the Hospital?

Rachael Chait is a rising fourth-year medical student. The fire alarm is blaring in my ears in the ICU. I make eye contact with my

May 27, 2024

The benefits and harms of screening for anxiety disorders in asymptomatic adults

Researchers examined the different aspects of screening for anxiety disorders in adults.

June 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.